As part of a randomized controlled trial, a team from Lawson Health Research Institute is the first in the world
Read more
Home »
Calquence approved to treat CLL, SLL
(HealthDay)—The U.S. Food and Drug Administration has granted supplemental approval to Calquence (acalabrutinib) for treatment of chronic lymphocytic leukemia (CLL)
Read more
Drug approved to treat tenosynovial giant cell tumor
(HealthDay)—Turalio (pexidartinib) capsules have been approved to treat adults with symptomatic tenosynovial giant cell tumor (TGCT), the U.S. Food and
Read more
Vaccine developed to treat osteoarthritic pain by blocking nerve growth factor
In a collaborative effort between the Jenner Institute and the Kennedy Institute of Rheumatology at the University of Oxford, with
Read more
Study identifies new target to prevent, treat alcoholism
New research conducted at OHSU in Portland, Oregon, identifies a gene that could provide a new target for developing medication
Read more